8037 — China Biotech Services Holdings Share News
0.000.00%
Last trade - 00:00- HK$482.99m
- HK$924.61m
- HK$73.50m
Brief: China Biotech Services Says Guoyuan Securities Investment (Hong Kong) To Subscribe For Convertible Bonds
Brief: China Biotech Services Says Chui Hoi Yam Appointed As An Executive Director
Brief: China Biotech Services Posts Qtrly Profit Attributable Of HK$91.3 Million
Brief: China Biotech Services Announces Cooperation Framework Deal
Brief: China Biotech Services Sees Net Profit Attributable Of Not Less Than Hk$150 MLN For 9M
Brief: China Biotech Services Records Qtrly Profit Hk$99.8 Mln
Brief: China Biotech Services Sees Net Profit Attributable For Six Months Of Not Less Than Hk$65 Million
Brief: China Biotech Services Says Co And Shanghai Branch Of Ping An Health Cloud Entered Into Strategic Cooperation Framework Agreement
Brief: China Biotech Services Announces Acquisition Of BNCT Parts
Brief: China Biotech Services Says Wang Zheng, An Executive Director, Will Be Re-Designated As A Non-Executive Director
Brief: China Biotech Services Says Qtrly Turnover HK$384.1 Million
Brief: China Biotech Services Expects Net Profit Attributable Of Not Less Than Hk$34 Mln For Q1
Brief: China Biotech Services Says Unit Entered Into A Joint Venture Agreement With Sure Metro Ltd
Brief: China Biotech Services Expects Consolidated Net Profit Attributable Of Not Less Than HK$17 Mln For Year
Brief: China Biotech Services Says Unit Entered Site Admission & Investment Deal
Brief: China Biotech Services Says SDCL & BGI Entered Supplemental Master Supply Deal To Increase 2022 Annual Cap From Hk$80 Million To HK$400 Mln For Year
Brief: China Biotech Services Says Unit Entered Into Term Sheet With Qianhai Devin Capital Management (Shenzhen)
Brief: China Biotech Services Says Boao Lecheng Pilot Zone Agreed That BNCT Cancer Treatment Centre Project May Start Construction
Brief: China Biotech Services Posts QTRLY Turnover Of HK$131.2 Million